Skip to main content
. 2014 Dec 21;3(11):e963406. doi: 10.4161/21624011.2014.963406

Figure 2.

Figure 2.

Detection of TNF inhibitory soluble factors and VEGF in the serum of melanoma patients. Serum from melanoma patients was collected at different time points: baseline, 2 hours, 1 month and 2 months post-treatments. The presence in the serum of chromogranin A (CgA), soluble tumor necrosis factor (sTNFR) was assessed by ELISA. Statistical analysis of differences between means of soluble factors was performed by 2-tailed Student's t-test with significance defined as p < 0.05.